Abstract
RNA repeat expansions cause >30 diseases, and both oligonucleotides and small molecules have been developed to inhibit their dysfunction. Benhamou et al. show for the first time that small molecules targeting structured, disease-causing RNAs can shunt them toward native decay pathways by affecting their processing.
| Original language | English |
|---|---|
| Pages (from-to) | 223-231.e4 |
| Journal | Cell Chemical Biology |
| Volume | 27 |
| Issue number | 2 |
| DOIs | |
| State | Published - 20 Feb 2020 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2020 Elsevier Ltd
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- RNA
- chemical biology
- click chemistry
- drug design
- intron retention
- medicinal chemistry
- microsatellite disease
- myotonic dystrophy
- nucleic acids
- repeat expansion disorder
Fingerprint
Dive into the research topics of 'A Toxic RNA Catalyzes the Cellular Synthesis of Its Own Inhibitor, Shunting It to Endogenous Decay Pathways'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver